About the Business

Industry-leading Biotech and Nutraceutical Business for Sale - Biotech Business for Sale - Nutraceutical Business Acquisition - Microbiome Technology Business

Discover a rare opportunity to acquire a pioneering biotech and nutraceutical business specialising in microbiome and DNA technologies for disorder detection, prevention and treatment. With a robust patent portfolio, including US and EU-approved intellectual property for gut dysbiosis and a proprietary microbiome database, this business delivers clinically validated testing protocols with 99.9% accuracy and is positioned advantageously in a lucrative, high-growth sector!

*Global scalability: Operates through an established Canadian entity, providing seamless international market access and ensuring fully validated testing protocols that meet varying compliance standards across regions, positioning the business for.
*Diverse Revenue Streams: Generates income through product validation services, specialised diagnostic testing, formulation licensing, R&D partnerships and practitioner education.
*Proprietary Database: Holds rare multidisciplinary expertise in molecular genetics, nutrigenomics and advanced testing methodologies, backed by a curated microbiome database that allows for unique insights into supplement mechanisms, pre/probiotics and postbiotics that generate clinically relevant insights across multiple therapeutic pathways
*Market-ready Formulations: Requires minimal additional R&D investment for commercialisation given its market-ready formulations, including specialised gut fibre, zinc bioavailability enhancers with antiviral properties and an advanced microbiome-specific sugar formulation developed by a European manufacturer.
*Robust Partnerships: Strategically partnered with accredited facilities and leading institutions across multiple countries, providing access to cutting-edge technology without ownership costs and enabling testing and development work across Australia, Canada and the US.
*Government Contracts: Currently engaged with government bodies, showcasing market credibility and establishing pathways for further governmental contracts.
*Huge Market Expansion Potential: Multiple patents and testing capabilities can be leveraged to capitalise on the growing consumer interest in gut health and overall wellness.

Global Market Snapshot:
*Wellness market valued at $1.5 trillion; growth at 5% to 10% annually.
*Probiotics market valued at USD 87.70 billion in 2023; growth at a CAGR of 14.1% from 2024 to 2030.
*Immune health supplements market valued at USD 26.60 billion